content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <cik>0001856296</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001635088</issuerCik>
        <issuerName>Roivant Sciences LTD</issuerName>
        <secFileNumber>001-40782</secFileNumber>
        <issuerAddress>
          <com:street1>c/o Roivant Sciences Ltd. 7th Floor,</com:street1>
          <com:street2>50 Broadway</com:street2>
          <com:city>london</com:city>
          <com:stateOrCountry>X0</com:stateOrCountry>
          <com:zipCode>SW1H 0DB</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>207 400 3347</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Kumar Rakhi</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>Officer</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>Fidelity Brokerage Services LLC</name>
          <address>
            <com:street1>245 Summer St</com:street1>
            <com:city>Boston</com:city>
            <com:stateOrCountry>MA</com:stateOrCountry>
            <com:zipCode>02110</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>87830</noOfUnitsSold>
        <aggregateMarketValue>762283.86</aggregateMarketValue>
        <noOfUnitsOutstanding>758427350</noOfUnitsOutstanding>
        <approxSaleDate>04/26/2023</approxSaleDate>
        <securitiesExchangeName>nasdaq</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>common</securitiesClassTitle>
        <acquiredDate>04/26/2023</acquiredDate>
        <natureOfAcquisitionTransaction>option exercise</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Roivant Sciences</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>34641</amountOfSecuritiesAcquired>
        <paymentDate>04/26/2023</paymentDate>
        <natureOfPayment>wire</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>common</securitiesClassTitle>
        <acquiredDate>04/26/2023</acquiredDate>
        <natureOfAcquisitionTransaction>option exercise</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Roivant Sciences</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>53189</amountOfSecuritiesAcquired>
        <paymentDate>04/26/2023</paymentDate>
        <natureOfPayment>wire</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>Rakhi Kumar</name>
          <address>
            <com:street1>c/o Roivant Sciences Ltd. 7th Floor</com:street1>
            <com:street2>50 Broadway</com:street2>
            <com:city>London</com:city>
            <com:stateOrCountry>X0</com:stateOrCountry>
            <com:zipCode>SW1H 0DB</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>common</securitiesClassTitle>
        <saleDate>02/21/2023</saleDate>
        <amountOfSecuritiesSold>3103</amountOfSecuritiesSold>
        <grossProceeds>26747.86</grossProceeds>
      </securitiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>Rakhi Kumar</name>
          <address>
            <com:street1>c/o Roivant Sciences Ltd. 7th Floor</com:street1>
            <com:street2>50 Broadway</com:street2>
            <com:city>london</com:city>
            <com:stateOrCountry>X0</com:stateOrCountry>
            <com:zipCode>SW1H 0DB</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>common</securitiesClassTitle>
        <saleDate>03/20/2023</saleDate>
        <amountOfSecuritiesSold>3098</amountOfSecuritiesSold>
        <grossProceeds>26983.58</grossProceeds>
      </securitiesSoldInPast3Months>
      <noticeSignature>
        <noticeDate>04/26/2023</noticeDate>
        <planAdoptionDates>
          <planAdoptionDate>02/25/2023</planAdoptionDate>
        </planAdoptionDates>
        <signature>Jason, as a duly authorized representative of National Financial Services LLC, as attorney-in-fact for officers name Rakhi Kumar</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 4814}]
text: 144
  0001856296
  XXXXXXXX
  LIVE
  0001635088
  Roivant Sciences LTD
  001-40782
  c/o Roivant Sciences Ltd. 7th Floor,
  50 Broadway
  london
  X0
  SW1H 0DB
  207 400 3347
  Kumar Rakhi
  Officer
  Common
  Fidelity Brokerage Services LLC
  245 Summer St
  Boston
  MA
  02110
  87830
  762283.86
  758427350
  04/26/2023
  nasdaq
  common
  04/26/2023
  option exercise
  Roivant Sciences
  N
  34641
  04/26/2023
  wire
  common
  04/26/2023
  option exercise
  Roivant Sciences
  N
  53189
  04/26/2023
  wire
  N
  Rakhi Kumar
  c/o Roivant Sciences Ltd. 7th Floor
  50 Broadway
  London
  X0
  SW1H 0DB
  common
  02/21/2023
  3103
  26747.86
  Rakhi Kumar
  c/o Roivant Sciences Ltd. 7th Floor
  50 Broadway
  london
  X0
  SW1H 0DB
  common
  03/20/2023
  3098
  26983.58
  04/26/2023
  02/25/2023
  Jason, as a duly authorized representative of National Financial Services LLC, as attorney-in-fact for officers name Rakhi Kumar